Unique ID issued by UMIN | UMIN000052361 |
---|---|
Receipt number | R000058358 |
Scientific Title | A Comparative Study of Pregnancy Rates Before and After Insurance Coverage of Assisted Reproductive Treatment (ART) in Japan |
Date of disclosure of the study information | 2023/10/01 |
Last modified on | 2025/04/01 14:09:09 |
A Comparative Study of Pregnancy Rates Before and After Insurance Coverage of Assisted Reproductive Treatment (ART) in Japan
A Comparative Study of Pregnancy Rates Before and After Insurance Coverage of Assisted Reproductive Treatment (ART) in Japan
A Comparative Study of Pregnancy Rates Before and After Insurance Coverage of Assisted Reproductive Treatment (ART) in Japan
A Comparative Study of Pregnancy Rates Before and After Insurance Coverage of Assisted Reproductive Treatment (ART) in Japan
Japan |
infertility
Obstetrics and Gynecology |
Others
NO
The purpose of this retrospective case-control study is to compare the pregnancy outcomes of first-time embryo transfers performed before insurance coverage with those performed after insurance coverage.
Efficacy
Continuing pregnancy rate at 9 weeks gestation
Interventional
Factorial
Non-randomized
Open -no one is blinded
Active
2
Treatment
Medicine | Maneuver |
Privately funded embryo transfers, which have been performed prior to insurance coverage (drugs used vary from institution to institution). In this study, Proginova was used for estrogen replacement and Duphaston for progesterone replacement.
Embryo transfers using insurance-approved drugs performed after insurance coverage. In this study, Estrana Tape, Estrogel, or Jurina was used for estrogen replacement, and Utrogestan, Lutinas, or Wankrinon for progesterone replacement.
20 | years-old | <= |
43 | years-old | > |
Female
(1) under 43 years of age (based on the conditions for ART insurance coverage in Japan), (2) first embryo transfer cycle, (3) frozen-thawed embryo transfer performed with endometrial adjustment using hormone replacement therapy, (3) no previous pregnancy, (4) no uterine malformation (endometrial polyp, bicornuate uterus, uterine myoma/hysterosalpingomyosis > 5 cm, endometrial thinning (5) No known chromosomal abnormality; (6) Written consent for participation in clinical research confirmed.
(1) cases who requested PGT-A, and (2) cases who withdrew their consent to participate in clinical research through procedures after participation in the study.
1500
1st name | Shinnosuke |
Middle name | |
Last name | Komiya |
HORAC Grand Front Osaka Clinic
Gynecology
530-0011
Grand Frront Osaka Tower B 15F, 3-1, Ofuka-cho, Kita-ku, Osaka city, Osaka, Japan
0636778824
komiya0703@gmail.com
1st name | Shinnosuke |
Middle name | |
Last name | Komiya |
HORAC Grand Front Osaka Clinic
Gynecology
530-0011
Grand Frront Osaka Tower B 15F, 3-1, Ofuka-cho, Kita-ku, Osaka city, Osaka, Japan
0636778824
komiya0703@gmail.com
HORAC Grand Front Osaka Clinic
None
Self funding
HORAC Grand Front Osaka Clinic
Grand Frront Osaka Tower B 15F, 3-1, Ofuka-cho, Kita-ku, Osaka city, Osaka, Japan
0636778824
komiya0703@gmail.com
NO
2023 | Year | 10 | Month | 01 | Day |
Partially published
1182
No significant difference was observed in the rates of clinical pregnancy between the insurance-covered treatment group and the self-pay treatment group (OR=0.95, [95% CI: 0.66-1.36], p=0.76).
2023 | Year | 09 | Month | 30 | Day |
Delay expected |
The release of results will be delayed due to ongoing manuscript preparation.
Completed
2023 | Year | 04 | Month | 01 | Day |
2023 | Year | 04 | Month | 10 | Day |
2023 | Year | 05 | Month | 28 | Day |
2024 | Year | 04 | Month | 01 | Day |
2025 | Year | 03 | Month | 31 | Day |
2025 | Year | 03 | Month | 31 | Day |
2025 | Year | 03 | Month | 31 | Day |
2023 | Year | 09 | Month | 30 | Day |
2025 | Year | 04 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058358